CD44 and cancer: Tamada et al. found that CD44 interacted with pyruvate kinase M2 and enhanced glycolysis in p53-deficient or hypoxic cancer cells (92); CD44 knockdown then switched the metabolic flux from glycolysis to mitochondrial respiration and increased intracellular levels of ROS.